Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|35|5574-5593

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.35, 2014-10, pp. : 5574-5593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-&kgr;B as a therapeutic target in neurodegenerative diseases

By Camandola Simonetta   Mattson Mark P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 123-132

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1513-1529

Bentham Science Publishers

Access to resources Recommend Favorite

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

By  

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2918-2929

Bentham Science Publishers

Access to resources Recommend Favorite